x |
Quarterly
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
for the quarterly period ended June 30,
2007.
|
o |
Transition
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Delaware
|
|
77-0312442
|
(State
or other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer Number)
|
PART
I –
FINANCIAL INFORMATION
|
||
Item
1. Condensed Consolidated Financial Statements
|
||
|
Condensed
Consolidated Balance Sheets at June 30, 2007 (unaudited) and December
31,
2006*
|
1
|
Unaudited
Condensed Consolidated Statements of Operations for the Six and Three
Months Ended June 30, 2007 and 2006
|
2
|
|
Unaudited
Condensed Consolidated Statements of Stockholders’ Deficit for the Six
Months Ended June 30, 2007
|
3
|
|
Unaudited
Condensed Consolidated Statements of Cash Flows for the Six Months
Ended
June 30, 2007 and 2006
|
4
|
|
Notes
to Condensed Consolidated Financial Statements
|
5
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
13
|
|
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
18
|
|
Item
4. Controls and Procedures
|
19
|
|
PART
II – OTHER INFORMATION
|
||
Item
1. Legal Proceedings
|
19
|
|
Item
1A. Risk Factors
|
19
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
19
|
|
Item
3. Defaults upon Senior Securities
|
19
|
|
Item
4. Submission of Matters to a Vote of Security Holders
|
19
|
|
Item
5. Other Information
|
19
|
|
Item
6. Exhibits
|
20
|
|
Signatures
|
21
|
|
Certifications
|
22
|
* |
The
Condensed Consolidated Balance Sheet at December 31, 2006 has been
derived
from the audited consolidated financial statements filed as an exhibit
to
our Report on Form 10-K on June 6, 2007.
|
June
30, 2007
|
December
31,
2006
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
712
|
$
|
2,153
|
|||
Accounts
receivable, net of allowance for doubtful accounts of $136 and $121;
respectively
|
2,712
|
2,748
|
|||||
Prepaid
expenses and other current assets
|
476
|
327
|
|||||
Total
current assets
|
3,900
|
5,228
|
|||||
Property
and equipment, net
|
2,530
|
2,762
|
|||||
Other
assets
|
318
|
403
|
|||||
Total
assets
|
$
|
6,748
|
$
|
8,393
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
2,575
|
$
|
1,957
|
|||
Accrued
expenses
|
2,206
|
1,906
|
|||||
Customer
deposits
|
109
|
102
|
|||||
Accrued
sales taxes and regulatory fees
|
4,130
|
4,216
|
|||||
Derivative
financial instruments
|
5,401
|
4,301
|
|||||
Senior
secured convertible notes, net of discount of $900 and $2,280,
respectively
|
6,067
|
4,326
|
|||||
Deferred
revenue
|
267
|
288
|
|||||
Total
current liabilities
|
20,755
|
17,096
|
|||||
Preferred
stock, $.0001 par value; 5,000 shares authorized and redeemable;
0.120
Series B shares issued and outstanding, (stated value of $2,888;
liquidation value of $3,907 and $3,735, respectively)
|
2,888
|
2,888
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders’
deficit:
|
|||||||
Common
stock, $.0001 par value; 100,000 shares authorized; 47,550 and 46,390
shares issued and issuable; 47,510 and 46,350 shares outstanding,
respectively
|
5
|
5
|
|||||
Additional
paid-in capital
|
161,645
|
161,267
|
|||||
Accumulated
deficit
|
(178,305
|
)
|
(172,623
|
)
|
|||
(16,655
|
)
|
(11,351
|
)
|
||||
Less:
Treasury stock, 40 shares at cost
|
(240
|
)
|
(240
|
)
|
|||
Total
stockholders’ deficit
|
(16,895
|
)
|
(11,591
|
)
|
|||
Total
liabilities and stockholders’ deficit
|
$
|
6,748
|
$
|
8,393
|
|||
|
Six
Months Ended June 30,
|
Three
Months Ended June 30,
|
|||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Revenue
|
$
|
11,508
|
$
|
9,702
|
$
|
5,847
|
$
|
4,981
|
|||||
Cost
of revenue
|
7,806
|
6,836
|
3,897
|
3,350
|
|||||||||
Gross
margin
|
3,702
|
2,866
|
1,950
|
1,631
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development
|
325
|
474
|
164
|
203
|
|||||||||
Sales
and marketing
|
1,477
|
1,374
|
831
|
645
|
|||||||||
General
and administrative
|
4,339
|
7,458
|
2,388
|
2,805
|
|||||||||
Total
operating expense
|
6,141
|
9,306
|
3,383
|
3,653
|
|||||||||
Loss
from operations
|
(2,439
|
)
|
(6,440
|
)
|
(1,433
|
)
|
(2,022
|
)
|
|||||
Other
expense (income):
|
|||||||||||||
Interest
expense
|
2,004
|
2,415
|
1,089
|
777
|
|||||||||
Interest
income
|
(28
|
)
|
(41
|
)
|
(13
|
)
|
(37
|
)
|
|||||
Increase
in fair value of derivative financial instruments
|
1,006
|
579
|
392
|
602
|
|||||||||
Amortization
of deferred financing costs
|
261
|
129
|
131
|
129
|
|||||||||
Total
other expense, net
|
3,243
|
3,082
|
1,599
|
1,471
|
|||||||||
Net
loss
|
(5,682
|
)
|
(9,522
|
)
|
(3,032
|
)
|
(3,493
|
)
|
|||||
Preferred
stock dividends
|
(172
|
)
|
(172
|
)
|
(87
|
)
|
(87
|
)
|
|||||
Net
loss attributable to common stockholders
|
$
|
(5,854
|
)
|
$
|
(9,694
|
)
|
$
|
(3,119
|
)
|
$
|
(3,580
|
)
|
|
Net
loss attributable to common stockholders per share:
|
|||||||||||||
Basic
and diluted
|
$
|
(0.13
|
)
|
$
|
(0.21
|
)
|
$
|
(0.07
|
)
|
$
|
(0.08
|
)
|
|
Weighted
average number of common shares:
|
|||||||||||||
Basic
and diluted
|
46,762
|
46,127
|
46,982
|
46,207
|
Common
Stock
|
Paid
In
|
Accumulated
|
Treasury
Stock
|
|||||||||||||||||||
Shares
|
Amount
|
Capital
|
Deficit
|
Shares
|
Amount
|
Total
|
||||||||||||||||
Balance
at January 1, 2007
|
46,390
|
$
|
5
|
$
|
161,267
|
$
|
(172,623
|
)
|
40
|
$
|
(240
|
)
|
$
|
(11,591
|
)
|
|||||||
Net
loss
|
—
|
—
|
—
|
(5,682
|
)
|
—
|
—
|
(5,682
|
)
|
|||||||||||||
Comprehensive
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(5,682
|
)
|
||||||||||||||
Stock-based
compensation - options
|
—
|
—
|
274
|
—
|
—
|
—
|
274
|
|||||||||||||||
Stock-based
compensation - restricted stock
|
1,160
|
—
|
276
|
—
|
—
|
—
|
276
|
|||||||||||||||
Preferred
stock dividends
|
—
|
—
|
(172
|
)
|
—
|
—
|
—
|
(172
|
)
|
|||||||||||||
Balance
at June 30, 2007
|
47,550
|
$
|
5
|
$
|
161,645
|
$
|
(178,305
|
)
|
40
|
$
|
(240
|
)
|
$
|
(16,895
|
)
|
Six Months Ended
June
30,
|
|||||||
2007
|
2006
|
||||||
Cash
flows from Operating Activities:
|
|||||||
Net
loss
|
$
|
(5,682
|
)
|
$
|
(9,522
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Depreciation
and amortization
|
779
|
1,013
|
|||||
Expense
recognized for the increase in the estimated fair value of the derivative
financial instruments
|
1,006
|
579
|
|||||
Amortization
of deferred financing costs
|
261
|
129
|
|||||
Accretion
of discount on Convertible Notes
|
1,380
|
369
|
|||||
Beneficial
conversion feature for Convertible Notes
|
94
|
1,768
|
|||||
Loss
on disposal of equipment
|
8
|
30
|
|||||
Stock-based
compensation
|
550
|
530
|
|||||
Increase
(decrease) in cash attributable to changes in assets and
liabilities:
|
|||||||
Accounts
receivable
|
36
|
(145
|
)
|
||||
Prepaid
expenses and other current assets
|
(149
|
)
|
23
|
||||
Other
assets
|
(176
|
)
|
205
|
||||
Accounts
payable
|
618
|
692
|
|||||
Customer
deposits
|
7
|
—
|
|||||
Accrued
expenses, sales taxes and regulatory fees
|
403
|
1,104
|
|||||
Deferred
revenue
|
(21
|
)
|
(74
|
)
|
|||
Net
cash used in operating activities
|
(886
|
)
|
(3,299
|
)
|
|||
Cash
flows from Investing Activities:
|
|||||||
Proceeds
from disposal of property and equipment
|
—
|
27
|
|||||
Purchases
of property and equipment
|
(555
|
)
|
(478
|
)
|
|||
Net
cash used in investing activities
|
(555
|
)
|
(451
|
)
|
|||
Cash
flows from Financing Activities:
|
|||||||
Proceeds
from issuance of Convertible Notes, net of financing costs of
$595
|
—
|
5,585
|
|||||
Net
cash provided by financing activities
|
—
|
5,585
|
|||||
(Decrease)
increase in cash and cash equivalents
|
(1,441
|
)
|
1,835
|
||||
Cash
and cash equivalents at beginning of period
|
2,153
|
2,023
|
|||||
Cash
and cash equivalents at end of period
|
$
|
712
|
$
|
3,858
|
|||
Supplemental
disclosures of cash flow information:
|
|||||||
Cash
paid during the period for
|
|||||||
Interest
|
$
|
2
|
$
|
—
|
|||
Non-cash
investing and financing activities:
|
|||||||
Preferred
stock dividends
|
$
|
172
|
$
|
172
|
|||
Additional
Convertible Notes issued as payment for interest
|
361
|
103
|
|||||
Deferred
financing costs for Convertible Notes incurred by issuance of placement
agent warrants
|
—
|
296
|
Six Months Ended June 30,
|
Three Months Ended June 30,
|
||||||
2007
|
2006
|
2007
|
2006
|
||||
Risk
free interest rate
|
4.7%
|
4.8%
|
4.7%
|
4.9%
|
|||
Expected
option lives
|
5
Years
|
5
Years
|
5
Years
|
5
Years
|
|||
Expected
volatility
|
99.8%
|
95.4%
|
99.8%
|
95.3%
|
|||
Estimated
forfeiture rate
|
10%
|
30%
|
10%
|
30%
|
|||
Expected
dividend yields
|
None
|
None
|
None
|
None
|
|||
Weighted
average grant date fair value of options
|
$0.43
|
$0.30
|
$0.43
|
$0.29
|
Outstanding
|
Exercisable
|
||||||||||||
|
Number
of Options |
Weighted
Average
Exercise
Price
|
Number
of Options
|
Weighted
Average
Exercise
Price
|
|||||||||
Options
outstanding, January 1, 2007
|
5,100
|
$
|
2.26
|
3,664
|
$
|
2.86
|
|||||||
Granted
|
911
|
0.57
|
|||||||||||
Exercised
|
—
|
—
|
|||||||||||
Expired
|
(1,360
|
)
|
2.95
|
||||||||||
Forfeited
|
(685
|
)
|
2.88
|
||||||||||
Options
outstanding, June 30, 2007
|
3,966
|
$
|
1.53
|
2,262
|
$
|
2.15
|
|
Restricted
Shares
|
Weighted
Average
Exercise
Price
|
|||||
Unvested
restricted shares outstanding, January 1, 2007
|
317
|
$
|
0.71
|
||||
Granted
|
1,160
|
0.57
|
|||||
Vested
|
(484
|
)
|
0.69
|
||||
Forfeited
|
—
|
—
|
|||||
Unvested
restricted shares outstanding, June 30, 2007
|
993
|
$
|
0.53
|
Dec.
31, 2006
|
Activity
|
June
30, 2007
|
||||||||
Principal
of Convertible Notes:
|
||||||||||
March
2006 financing
|
$
|
5,665
|
$
|
—
|
$
|
5,665
|
||||
April
2006 financing
|
515
|
—
|
515
|
|||||||
Additional
Convertible Notes
|
426
|
361
|
787
|
|||||||
6,606
|
361
|
6,967
|
||||||||
Discount:
|
||||||||||
Derivative
financial instrument - Series A Warrants
|
(2,873
|
)
|
—
|
(2,873
|
)
|
|||||
Reduction
of exercise price and extension of expiration dates of
warrants
|
(766
|
)
|
—
|
(766
|
)
|
|||||
(3,639
|
)
|
—
|
(3,639
|
)
|
||||||
Accretion
of discount
|
1,359
|
1,380
|
2,739
|
|||||||
(2,280
|
)
|
1,380
|
(900
|
)
|
||||||
Convertible
Notes, net of discount
|
$
|
4,326
|
$
|
1,741
|
$
|
6,067
|
June 30,
2007
|
||||
Cash
financing costs:
|
||||
Placement
agent fees –
Burnham
Hill Partners
|
$
|
480
|
||
Other
financing costs
|
115
|
|||
595
|
||||
Non-cash
financing costs:
|
||||
Placement
agent warrants –
Burnham
Hill Partners
|
296
|
|||
Financing
costs charged to additional paid in capital
|
(110
|
)
|
||
Total
financing costs
|
781
|
|||
Accumulated
amortization
|
(650
|
)
|
||
$
|
131
|
Dec. 31,
2006
|
Additions
|
Increase
(decrease)
in
Fair
Value
|
June
30,
2007
|
||||||||||
Derivative
financial instrument –
February
2004 capital raise
|
$
|
1,236
|
$
|
—
|
$
|
(13
|
)
|
$
|
1,223
|
||||
Derivative
financial instrument –
Beneficial
conversion feature –
Convertible
Notes
|
1,666
|
94
|
—
|
1,760
|
|||||||||
Derivative
financial instrument –
Series A
Warrants
|
1,399
|
—
|
1,019
|
2,418
|
|||||||||
$
|
4,301
|
$
|
94
|
$
|
1,006
|
$
|
5,401
|
Six Months Ended June 30,
|
Three Months Ended June 30,
|
||||||||||||
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
||||
Accretion
of discount on Convertible Notes
|
$
|
1,380
|
$
|
369
|
$
|
752
|
$
|
369
|
|||||
Interest
on Convertible Notes
|
374
|
155
|
207
|
155
|
|||||||||
Beneficial
conversion feature –
Convertible
Notes
|
94
|
1,768
|
53
|
182
|
|||||||||
Interest
expense for sales and use taxes and regulatory fees
|
154
|
123
|
76
|
71
|
|||||||||
Other
interest expense
|
2
|
—
|
1
|
—
|
|||||||||
$
|
2,004
|
$
|
2,415
|
$
|
1,089
|
$
|
777
|
(Unaudited)
Six Months Ended
June
30,
|
(Unaudited)
Three Months Ended
June
30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Cost
of revenue
|
67.8
|
70.5
|
66.6
|
67.3
|
|||||||||
Gross
margin
|
32.2
|
29.5
|
33.4
|
32.7
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research
and development
|
2.8
|
4.9
|
2.8
|
4.1
|
|||||||||
Sales
and marketing
|
12.8
|
14.2
|
14.2
|
12.9
|
|||||||||
General
and administrative
|
37.7
|
76.9
|
40.8
|
56.3
|
|||||||||
Total
operating expenses
|
53.3
|
96.0
|
57.8
|
73.3
|
|||||||||
Loss
from operations
|
(21.1
|
)
|
(66.5
|
)
|
(24.4
|
)
|
(40.6
|
)
|
|||||
Other
expense (income):
|
|||||||||||||
Interest
expense
|
17.4
|
24.8
|
18.6
|
15.5
|
|||||||||
Interest
income
|
(0.2
|
)
|
(0.4
|
)
|
(0.2
|
)
|
(0.7
|
)
|
|||||
Increase
in fair value of derivative financial instruments
|
8.7
|
6.0
|
6.7
|
12.1
|
|||||||||
Amortization
of deferred financing costs
|
2.3
|
1.3
|
2.2
|
2.6
|
|||||||||
Total
other expense, net
|
28.2
|
31.7
|
27.3
|
29.5
|
|||||||||
Net
loss
|
(49.3
|
)
|
(98.2
|
)
|
(51.7
|
)
|
(70.1
|
)
|
|||||
Preferred
stock dividends
|
(1.5
|
)
|
(1.8
|
)
|
(1.5
|
)
|
(1.7
|
)
|
|||||
Net
loss attributable to common stockholders
|
(50.8
|
)%
|
(100.0
|
)%
|
(53.2
|
)%
|
(71.8
|
)%
|
Contractual
Obligations:
|
Total
|
Less Than
1
Year
|
1-3 Years
|
3-5 Years
|
More than
5 Years
|
|||||||||||
Convertible
Notes
|
$
|
6,967
|
$
|
6,967
|
$
|
─
|
$
|
─
|
$
|
─
|
||||||
Derivative
liabilities
|
5,401
|
5,401
|
─
|
─
|
─
|
|||||||||||
Operating
lease obligations
|
135
|
129
|
6
|
─
|
─
|
|||||||||||
Commercial
commitments
|
4,951
|
2,729
|
2,222
|
─
|
─
|
|||||||||||
Total
|
$
|
17,454
|
$
|
15,226
|
$
|
2,228
|
$
|
─
|
$
|
─
|
As Reported
June
30,
2007
|
Common
Stock Price
Reduction
|
Common
Stock Price
Increase
|
||||||||
Common
stock price
|
$
|
0.59
|
$
|
0.49
|
$
|
0.69
|
||||
Balance
Sheet:
|
||||||||||
Derivative
financial instrument –
February
2004 capital raise
|
$
|
1,223
|
$
|
1,223
|
$
|
1,223
|
||||
Derivative
financial instrument – Beneficial conversion feature – Convertible
Notes
|
1,760
|
1,760
|
2,674
|
|||||||
Derivative
financial instrument – Series A Warrants
|
2,418
|
1,910
|
2,942
|
|||||||
Derivative
financial instruments
|
$
|
5,401
|
$
|
4,893
|
$
|
6,839
|
||||
Change
in fair value of derivative financial instruments
|
$
|
-
|
$
|
(508
|
)
|
$
|
1,438
|
|||
Consolidated
Statement of Operations:
|
||||||||||
Increase
in fair value of derivative financial instruments
|
$
|
1,006
|
$
|
498
|
$
|
2,444
|
||||
Net
loss attributable to common stockholders
|
$
|
(5,854
|
)
|
$
|
(5,346
|
)
|
$
|
(7,292
|
)
|
31.1
|
Rule
13a-14(a)/15d-14(a) Certificate of Chief Executive
Officer
|
|
31.2
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Financial
Officer
|
|
32.1
|
Certificate
of Chief Executive Officer pursuant to 18 U.S.C. Section 1350,
as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
Certificate
of Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
||
GLOWPOINT, INC. | ||
Registrant | ||
Date:
August 14, 2007
|
By: |
/s/
Michael Brandofino
|
Michael
Brandofino, Chief Executive Officer
(principal
executive officer)
|
||
Date:
August 14, 2007
|
By: |
/s/
Edwin F. Heinen
|
Edwin
F. Heinen, Chief Financial Officer
(principal
financial and accounting officer)
|